53results about How to "In line with modern medical research theory" patented technology

The invention discloses a traditional Chinese medicinal preparation for treating rheumatic low back and leg pain. The traditional Chinese medicinal preparation for treating the rheumatic low back and leg pain is prepared from the following medicinal materials in parts by weight: 60 parts of semen strychni, 7 parts of scorpio, 7 parts of earthworm, 7 parts of ground beetle, 5 parts of deer-horn glue, 3 parts of liquorice, 1 part of cinnabar, 15 parts of eel blood, 5 parts of Japanese peristrophe herb, 6 parts of allium cyaneum regel, 8 parts of rabdosia ternifolia, 4 parts of cleavers and 3 parts of doronicum altaicum pallas. Clinical experiments prove that appropriate medicinal materials and a ratio thereof are selected, the traditional Chinese medicinal preparation for treating the rheumatic low back and leg pain has the effects of dispelling wind and removing cold, activating meridians to stop pain and conditioning functions, and the traditional Chinese medicinal preparation for treating the rheumatic low back and leg pain is high in curative ratio and safe and produces no toxic or side effect when used for treating the rheumatic low back and leg pain.

The invention discloses a Chinese medicinal composition for treating postpartum rheumatism due to deficiency of qi and blood. The Chinese medicinal composition comprises the following medicinal materials in parts by weight: 45 parts of milkvetch roots, 21 parts of Chinese angelica, 12 parts of cassia twigs, 15 parts of white paeony roots, 25 parts of radix glycyrrhizae preparata, 15 parts of Chinese dates, 12 parts of divaricate saposhnikovia roots, 10 parts of fresh gingers, 12 parts of incised notopterygium, 10 parts of Azolla imbircata, 8 parts of wedelia urticifolia DC., 6 parts of swan goose oil, 5 parts of sea lavender, 5 parts of musk, 4 parts of eleutherine plicata herb and 6 parts of skins on boiled milk. Through the proving of clinical experiment, due to the selecting and combining of suitable medicinal materials, the Chinese medicinal composition has the efficacies of invigorating qi and blood, expelling wind, removing cold and tonifying and strengthening the constitution, can achieve a high recovery rate of postpartum rheumatism due to deficiency of qi and blood, is low in cost and safe and can not cause side and toxic effects.

The invention relates to the field of drug formulae, in particular to a traditional Chinese medicine for treating gastric ulcer. The traditional Chinese medicine is characterized by being prepared from the following raw materials in parts by weight: 77-87 parts of oroxylum indicum, 41-51 parts of greek valerian, 25-35 parts of radix ceratostigmae, 33-43 parts of roundleaf dutchmanspipe root, 25-35 parts of semen aesculi, 18-28 parts of fingered citron, 21-31 parts of bulbiferous stonescrop, 19-29 parts of amomum cardamomum, 14-24 parts of allium macrostemon, 20-30 parts of alpinia katsumadai, 13-23 parts of adiantum, 16-26 parts of semen cuscutae, 10-20 parts of dioscorea cirrhosa, 37-47 parts of jasminum grandiflorum, 24-34 parts of polygonum orientale fruit, 26-36 parts of pterocephalus hookeri, 8-18 parts of perfoliote knotweed herb, 6-16 parts of dwarf galangal rhizome and 8-18 parts of raspberries. The raw materials are mixed, soaked with water, decocted and subjected to residue removal to obtain filter liquor. The traditional Chinese medicine has a remarkable treatment effect on epigastric pain, gastric ulcer and duodenal ulcer, can improve the gastric motility and recover normal metabolism of the stomach, is long in action time, short in treatment course, quick-acting, safe and free of toxic and side effects, and can be widely applied to clinical treatment of the gastric ulcer.

The invention discloses an acupuncture and moxibustion physiotherapy ointment for external use. The ointment for external use comprises active ingredients which include, by weight, 10-20g of rosin, 10-20g of aloe, 10-20g of cutch, 10-20g of myrrh, 10-20g of olibanum, 10-20g of bulbophyllum radiatum Lindl., 8-12g of flexuose climbing fern herb, 8-12g of carthamus tinctorius, 8-12g of akebia stem, 8-12g of lygodium scandens (L.) Sw., 8-12g of star-flower lysimachia, 8-12g of Chinese angelica, 8-12g of pseudo-ginseng , 8-12g of fructus psoraleae, 8-12g of achyranthes bidentata, 8-12g of borneol and 150-200g of yellow wax. The acupuncture and moxibustion physiotherapy ointment for external use is superior in compatibility of medicines, reasonable in composition and capable of promoting blood circulation to remove meridian obstruction, dispersing blood stasis, relieving pain, caring the skin and diminishing inflammation and can achieve optimal acupuncture and moxibustion physiotherapy effects, make up acupuncture and moxibustion physiotherapy defects, shorten curing time greatly and relieve pain of patients, thereby being worthy of being popularized and applied widely clinically.

The invention discloses a traditional Chinese medicine preparation for treating hyperthyroidism. The traditional Chinese medicine preparation disclosed by the invention is prepared from the following medicinal materials in weight: 10 g of felwort, 10 g of cortex phellodendri, 10 g of raw arisaema consanguineum schott, 25 g of selfheal, 25 g of air potato, 25 g of yellow myrobalan peel, 5 g of semen sojae germinatum, 15 g of Lobaria retigera, 15 g of oriental blechnum frond, 15 g of rhizoma anemarrhenae, 8 g of radix bupleuri, 20 g of halogen alkaline, 8 g of dracocephalum heterophyllum, and 5 g of pig's thyroid gland. Found from clinical experiments, the obvious effect of effectively treating hyperthyroidism is achieved by selecting proper medicinal materials and a mixture ratio thereof; and furthermore, the traditional Chinese medicine preparation disclosed by the invention is safe and free from toxic and side effect.

The invention discloses a traditional Chinese medicine for treating sepsis. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 10 parts of rattletop, 15 parts of root of common peony, 10 parts of the root bark of the peony tree, 30 parts of honeysuckle flower, 15 parts of fructus forsythiae, 10 parts of red halloysite, 6 parts of raw rhubarb, 10 parts of Scutellaria baicalensis, 5 parts of Coptis chinensis, 8 parts of Commiphora mukul, 5 parts of patrinia, 10 parts of Radix Ophiopogonis, 5 parts of short-tube lycoris, 6 parts of the root of bidentate achyranthes, 5 parts of Mirabilis himalaica and 3 parts of Pouzolzia elegans. The clinical experiment proves that proper medicinal materials and ratios thereof are selected, the obvious effect of effectively treating the sepsis is achieved, and the traditional Chinese medicine is safe and does not have any toxic or side effect.

The invention discloses a pharmaceutical composition for preventing and treating enter radiation diseases. The pharmaceutical composition comprises FTY720 and linaclotide. Experiments prove that the synergistic effect can be achieved due to combined application of the two medicines of the FTY720 and the linaclotide, and intestinal tissue injury repair after radiation is obviously enhanced. The research result provides a specific medicine for treating the enter radiation diseases clinically, and the specific medicine has wide application prospect.

The invention discloses a traditional Chinese medicine decoction for treating cerebral infarction. The decoction is prepared from traditional Chinese medicinal materials in parts by weight as follows: 20 parts of white peony roots, 20 parts of calamus, 15 parts of round-root dutohmanspipe fruits, 10 parts of leeches, 12 parts of stiff silkworms, 10 parts of Chinese angelica, 8 parts of Teucrium viscidum, 12 parts of Syringa pinnatifolia, 4 parts of Pileostegia viburnoides, 12 parts of borneol, 4 parts of copperleaf herbs, 6 parts of all-grass of shore podgrass, 5 parts of Citrullus colocynthis, 5 parts of Sapium baccatum, 6 parts of wild jack beans, 6 parts of aizoon stonecrop herbs, 6 parts of snakegourd roots, 4 parts of Chinese thorowax roots, 4 parts of oysters, 14 parts of milkvetch roots, 6 parts of Halenia elliptica, 5 parts of Disporum cantoniense, 4 parts of flowers of Mesua ferrea, 3 parts of photinia stems, 3 parts of Indian mock strawberries and 2 parts of ginkgo pollen. Clinical experiments prove that through selection of the proper medicinal materials and ratio of the medicinal materials, the decoction has the significant effect in treating the cerebral infarction and is safe and free of toxic and side effects.

The invention discloses a medicine for treating convulsions caused by fear. The medicine is characterized by being prepared from the following raw material medicines in parts by weight: 5-9 parts of amber, 9-12 parts of star-flower lysimachia, 8-15 parts of poria cocos, 6-9 parts of carpesium abrotanoides, 8-12 parts of carpesium abrotanoides, 8-12 parts of tylophora florlbunda, 6-12 parts of uncaria rhynchophylla, 4-8 parts of bile arisaema, 10-18 parts of junci medulla, 10-20 parts of spina date seeds, 6-9 parts of peristrophe japonica and 7-10 parts of rhizoma anemarrhenae. The medicine has the excellent effects that the medicines are appropriately compatible, the traditional Chinese medicine and modern medicine research theories are met, and the effects of tonifying the spleen and kidney, dispelling wind and clearing heat, subduing liver-wind and relieving dizziness as well as clearing away the heart-fire and enlightening the mind are achieved; the medicine has a remarkable treatment effect on convulsions caused by fear, is short in treatment course, high in security, free of toxic or side effect and beneficial for sick children to relieve the diseases in time, and has an effect that the disease does not reoccur after being healed. The pharmacological testing and the clinical treatment effect observation show that the medicine has the characteristics of multiple effects, rapidness in taking effect, convenience in taking, easiness in absorption and safety and reliability. The medicine resources are easy to obtain, the cost of the medicines is low, and the burden of patients can be alleviated.

The invention discloses a traditional Chinese medicine decoction for treating children bronchial asthma. The decoction is prepared from the following traditional Chinese medicinal materials in parts by weight: 20 parts of radix astragali, 15 parts of codonopsis pilosula, 12 parts of phragmititis caulis, ephedra, 8 parts of ephedra, 6 parts of radix glycyrrhizae, 13 parts of nidus vespae, 4 parts of dried bodies of buthus martensii karsch, 3 parts of centipede, 7 parts of corylus avellana, 8 parts of lophatherum gracile, 5 parts of piper sarmentosum roxb, 6 parts of wild semen canavaliae, 8 parts of rhizoma polygonati, 8 parts of roots of straight ladybell, 6 parts of radix ophiopogonis, 8 parts of fructus lycii, 6 parts of radix paeoniae alba and 5 parts of leaves of Chinese ilex. Proved by clinical experiments, through the selection of appropriate medicinal materials and proportion thereof, the decoction achieves the remarkable efficacy of treating children bronchial asthma, and is safe and free of toxic and side effects.

The invention discloses a traditional Chinese medicine preparation for treating viral hepatitis. The traditional Chinese medicine preparation is prepared from the following raw materials as effective components: ammonia ester, cornus capitata, radix bupleuri, oriental wormwood, isatis roots, angelica sinensis, astragalus membranaceus, schisandra chinensis, burdock, rabdosia rubescens, rhizoma anemarrhenae, cardamom and irisquinone capsules. As the raw materials are compatible with one another, the traditional Chinese medicine preparation disclosed by the invention can meet the traditional Chinese medicine and modern medical research theories, has the effecacies of removing heat from the liver and removing toxicity, smoothing the liver and removing depression, promoting blood circulation to remove blood stasis, removing summer-heat and removing evil as well as tonifying spleen and kidney, has the function of effectively improving the body immunity and reducing the complication, is safe and free of toxic or side effect, realizes the purpose of treating both symptoms and root causes, and is worthy of clinical popularization and application,.

The invention discloses a traditional Chinese medicine capsule for treating children bronchial asthma. The capsule is prepared from the following traditional Chinese medicinal materials in parts by weight: 20 parts of radix astragali, 15 parts of radix codonopsis, 12 parts of phragmititis caulis, 8 parts of ephedra, 6 parts of radix glycyrrhizae, 13 parts of nidus vespae, 4 parts of dried bodies of buthus martensii karsch, 3 parts of centipede, 7 parts of roots of agapetes burmanica, 8 parts of lophatherum gracile, 5 parts of piper sarmentosum roxb, 6 parts of wild semen canavaliae, 8 parts of rhizoma polygonati, 8 parts of roots of straight ladybell, 6 parts of radix ophiopogonis, 8 parts of fructus lycii, 6 parts of radix paeoniae alba and 5 parts of pine pollen disruption powder. Proved by clinical experiments, through the selection of appropriate medicinal materials and proportion thereof, the capsule achieves the remarkable efficacy of treating children bronchial asthma, and is safe and free of toxic and side effects.

The invention discloses a traditional Chinese medicine capsule for treating sciatica. The traditional Chinese medicine capsule is prepared from the following medicinal materials in parts by weight: 30 parts of astragalus, 30 parts of dandelion pollen, 15 parts of milk peaches, 15 parts of salvia miltiorrhiza, 15 parts of roasted myrrh, 10 parts of radix achyranthis bidentatae, 10 parts of radix angelicae pubescentis, 10 parts of roasted olibanum, 10 parts of earthworms, 8 parts of medicinal flared roots, 4 parts of heartleaf saussurea roots, 5 parts of smallage seeds and 8 parts of mango stones. Clinical experiments prove that the remarkable effect on treating sciatica is achieved through selecting proper medicinal materials and the ratio of the medicinal materials; and the traditional Chinese medicine capsule is safe and free of toxic or side effect.

The invention discloses a traditional Chinese medicine capsule for treating prosopalgia. The traditional Chinese medicine capsule is characterized by being prepared from the following medicinal materials in parts by weight: 8-10 parts of Szechuan lovage rhizome, 8-10 parts of ipomoea purga hayne, 8-10 parts of scandent schefflera stem and leaf, 8-10 parts of incised notopterygium, 8-10 parts of dahurian angelica root, 8-3 parts of salt alkali, 8-10 parts of scorpion, 13-15 parts of centipede, 5-6 parts of wild mint, 5-6 parts of licorice root, 3-4 parts of salt alkali, 8-10 parts of corylus avellana, 0-5 parts of snow frog fat and 0-5 parts of rhizome of giant typhonium. A clinical experiment proves that by selecting appropriate medicinal materials and proportions, the traditional Chinese medicine capsule disclosed by the invention can achieve a significant effect of treating the prosopalgia, is definite in effect and short in cure time, is safe, and does not have toxic and side effects.

The invention discloses traditional Chinese medicine decoction for treating chronic superficial gastritis. The traditional Chinese medicine decoction is prepared from the following traditional Chinese medicinal materials in weight proportion: 15 parts of amomum aurantiacum, 8 parts of balaps japanensis yunnanensis mars, 4 parts of rhizoma coptidis, 12 parts of taraxacum mongolicum, 8 parts of radix salviae miltiorrhizae, 8 parts of rhizoma corydalis, 12 parts of radix paeoniae alba, 6 parts of liquorice, 6 parts of rhizoma atractylodis macrocephalae, 6 parts of fructus aurantii, 5 parts of radix aucklandiae, 6 parts of crystal soda, 5 parts of marsdenia tenacissima, 4 parts of morus nigra, 4 parts of rheum officinale, 5 parts of bark of terminalia chebula, 4 parts of spondias pinnata, 4 parts of ziziphus mauritiana, 5 parts of diospyros kaki silvestris, 6 parts of aizoon stonecrop herb and 4 parts of leaves of Chinese ilex. Clinical experiment results prove that through selecting the proper traditional Chinese medicinal materials according to the ratio, the decoction has the remarkable efficacy for treating chronic superficial gastritis, and is safe and free of toxic and side effect.

The invention discloses traditional Chinese medicine capsules for treating nocturia. The capsules are prepared from traditional Chinese medicinal materials in parts by weight as follows: 10 parts of Chinese yams, 7 parts of prepared rehmannia roots, 4 parts of oriental waterplantain rhizomes, 5 parts of tree peony bark, 1.5 parts of cassia bark, 6 parts of all-grass of bulley herminium, 9 parts of prepared common monkshood daughter roots, 6 parts of palmleaf raspberry fruits, 5 parts of semiaquilegia seeds, 4 parts of Borassus flabellifer, 3 parts of rhubarb, 6 parts of smallage seeds, 3 parts of Commiphora mukul, 4 parts of willow leaves, 6 parts of piptostegia roots and 9 parts of semen lepidii. Clinical experiments prove that through selection of the proper medicinal materials and ratio of the medicinal materials, the capsules have the significant effect of treating the nocturia and are safe and free of toxic and side effects.

The invention discloses a traditional Chinese medicine for treating hyperosteogeny arthritis. The traditional Chinese medicine is prepared from the following medicinal materials by weight: 10g of pubescent angelica root, 15g of mistletoe, 10g of large-leaf gentian root, 10g of eucommia bark, 10g of angelica sinensis, 10g of radix paeoniae alba, 10g of coix lachryma-jobi, 10g of Chuanxiong rhizome, 10g of cinnamon, 3g of amomum aurantiacum, 8g of Chinese milk vetch pollen, 5g of schefflera arboricola hayata, 8g of brine alkali and 4g of breynia fruticosa. Proved by clinical trials, through selecting appropriate medicinal materials and a proportioning ratio thereof, the traditional Chinese medicine achieves a remarkable effect on the treatment of hyperosteogeny arthritis, is safe and is free from toxic or side effects.

The invention belongs to the technical field of traditional Chinese medicines and relates to a folium artemisiae argyi containing traditional Chinese medicine composition for treating hemorrhagic shock and a preparation method thereof. The traditional Chinese medicine composition comprises the following traditional Chinese medicinal materials in parts by weight: 12-25 parts of folium artemisiae argyi, 11-24 parts of doubleteeth pubescent angelica, 6-16 parts of radix astragali, 6-15 parts of cyrtomium rhizome, 4-15 parts of prepared rhizome of adhesive rehmannia, 4-14 parts of ass-hide glue, 4-10 parts of dahurian angelica root, 3-9 parts of cassia bark, 4-9 parts of Chinese magnoliavine fruit, 3-9 parts of Chinese date, 2-10 parts of rice bean and 6-15 parts of liquorice root. The traditional Chinese medicine composition is simple in components and reasonable in ratio, is used for dialectical treatment based on the holism concept, has small toxic and side effects, has the functions of tonifying qi and yin and generating blood, warming yang, dispersing blood stasis and dredging collaterals and tonifying qi and the spleen, and has obvious curative effects on hemorrhagic shock.

The invention discloses a traditional Chinese medicine enema for treating severe acute pancreatitis. The enema is prepared from the following traditional Chinese medicinal materials in parts by weight: 10 parts of silene jenisseensis willd, 8 parts of radix paeoniae alba, 12 parts of fructus aurantii immaturus, 18 parts of radix scutellariae, 12 parts of cortex magnoliae officinalis, 25 parts of purple flower holly leaves, 10 parts of radix glycyrrhizae, 10 parts of yellow soybeans, 10 parts of common crabgrass herb, 13 parts of raw rhubarb, 15 parts of herb of diversifolious gueldenstaedtia, 12 parts of dandelion, 8 parts of thevetia peruviana, 6 parts of hydrocotyle sibthorpioides, 8 parts of hydnocarpus annamensis, 4 parts of wild cumin, 6 parts of erigeron breviscapus, 6 parts of triglochin martimum, 5 parts of ipomoea purga hayne roots, 5 parts of sapium baccatum roots, 6 parts of wild semen canavaliae, 6 parts of aizoon stonecrop herb and 6 parts of radix trichosanthis. Proved by clinical experiments, through the selection of appropriate medicinal materials and proportion thereof, the enema achieves the remarkable efficacy of treating severe acute pancreatitis, and is safe and free of toxic and side effects.

The invention discloses a traditional Chinese medicine preparation for treating enteric fever and paratyphoid fever. The traditional Chinese medicine preparation is prepared from the following crude drugs according to weight proportion: 6 grams of wrinkled gianthyssop, 7 grams of capillary Artemisia, 8 grams of talcum blocks, 8 grams of grassleaved sweetflag rhizome, 9 grams of scutellaria root, 10 grams of forsythia fruit, 11 grams of fruit of rosa davurica pall., 8 grams of garden sorrel, 20 grams of isodon tenuifolius, and 12 grams of root of narrowleaf screwtree. Clinical trials show that the traditional Chinese medicine preparation has the efficacies of nourishing the lung to keep the adverse qi downward, desslpating blood stasis, producing the body fluid, strengthening the body resistance and suppressing pathogenic factors by selecting proper crude drugs and the ratio thereof, is extremely high in the cure rate of enteric fever and paratyphoid fever, and is safe, and free of toxic and side effects, can prevent relevant complications to achieve the purpose of treating both symptoms and root causes, and is worth clinical promotion and application.

The invention discloses traditional Chinese medicine decoction for preventing and treating senile dementia. The traditional Chinese medicine decoction is prepared from the following traditional Chinese medicinal materials in weight proportion: 20 parts of prepared rehmannia root, 15 parts of rhizome of acorus calamus, 10 parts of radix polygoni multiflori, 25 parts of the root of red-rooted salvia, 10 parts of vinegar-quenched tortoise shell, 12 parts of dried mature seeds of corylus avellana, 18 parts of dried mature fruit of citrullus colocynthis, 8 parts of resina liquidamberis, 15 parts of Mongolian snakegourd root, 8 parts of Chinese thorowax root, 8 parts of oyster, 18 parts of distilled liquid of rose, 12 parts of eel blood, 8 parts of astragalus membranaceus, 12 parts of the fruit of Chinese wolfberry, 5 parts of dried mature fruit of cordia dichotoma, 5 parts of root of sapium baccatum, 6 parts of seeds and roots of wild sword bean, 6 parts of aizoon stonecrop herb and 4 parts of holly leaf. Clinical experiment results show that the remarkable efficacy of preventing and treating senile dementia is realized by selecting proper medicinal materials according to the ratio and high safety and no toxic or side effects are realized.

The invention discloses traditional Chinese medicine capsules for treating non-insulin-dependent diabetes mellitus. The traditional Chinese medicine capsules are prepared from, by weight, 4 parts of walnut oil, 5 parts of chimaphila umbellata, 7 parts of memorialis, 6 parts of alstonia leaves, 6 rhizomaBegonia fimbristipula Hance, 5 parts of Rhizoma Laportea Bulbifera, 5 parts of heart wood of Heliciopsis lobata (Merr.) Sleum., 4 parts of rhizome rehmannia, 5 parts of radix ophiopogonis, 4 parts of fruits of Chinese magnoliavine, 3 parts of Chinese yam, 4 parts of crotalaria sessiiflora, 8 parts of oyster, 10 parts of radices trichosanthis, 6 parts of medlar and 4 parts of radix puerariae. Clinical experiments prove that miao national herb memorialis and other traditional Chinese medicine materials are reasonably compatible, the non-insulin-dependent diabetes mellitus can be treated, complications can be effectively reduced, and the good effect of overall adjustment and long-term effect is achieved.

The invention discloses a traditional Chinese medicinal preparation for treating proliferation degenerative arthritis. The traditional Chinese medicinal preparation for treating the proliferation degenerative arthritis is prepared from the following medicinal materials in parts by weight: 20 parts of rhizoma drynariae, 20 parts of Yunnan rhizoma tupistrae chinensis, 20 parts of valeriana offeinalis, 8 parts of alkali, 6 parts of ammonia fat, 10 parts of schefflera delavayi, 15 parts of galbanum, 15 parts of marsdenia longipes, 10 parts of glossy privet fruit and 8 parts of oblongleaf kadsura stem root. Clinical applications prove that appropriate medicinal materials and a ratio thereof are selected, the traditional Chinese medicinal preparation for treating the proliferation degenerative arthritis has the effects of relaxing muscles and tendons, dredging blocked channels, promoting qi circulating to relieve pain and nourishing liver and kidney, and the traditional Chinese medicinal preparation for treating the proliferation degenerative arthritis is high in curative ratio and safe and produces no toxic or side effect when used for treating the proliferation degenerative arthritis.

The invention discloses traditional Chinese medicinal capsules for treating acute testitis. The traditional Chinese medicinal capsules are prepared from the following traditional Chinese medicinal materials in parts by weight: 12 parts of Indian kalimeris herb, 8 parts of goodyera brachystegia, 7 parts of scutellaria baicalensis, 6 parts of Chinese thorowax roots, 6 parts of oysters, 5 parts of morinda angustifolia, 6 parts of commiphora mukul, 8 parts of cortex albiziae, 7 parts of plantain herb, 8 parts of houttuynia cordata, 9 parts of prunella vulgaris, 10 parts of dandelions, 12 parts of halenia elliptica, 11 parts of zizyphus apetala, 9 parts of lepidium apetalum seeds, 5 parts of wild string beans, 6 parts of polygonatum, 7 parts of adenophora, 5 parts of ophiopogon japonicus, 6 parts of fructus lycii , 7 parts of radix paeoniae alba and 5 parts of pine pollen disruption powder. A clinical experiment shows that the remarkable effect of treating acute testitis can be achieved by selecting proper medicinal materials and a proper proportion and the traditional Chinese medicinal capsules are safe and free of toxic or side effects.

The invention belongs to the technical field of traditional Chinese medicine and discloses application of traditional Chinese medicine preparation containing Folium artemisiae argyi in preparing medicine for treating wind-warm lung-heat disease. The traditional Chinese medicine preparation is prepared from 18-25 parts of Folium artemisiae argyi, 17-26 parts of Gynostemma pentaphyllum, 17-23 parts of Folium isatidis, 13-18 parts of Radix scutellariae, 14-17 parts of Lespedeza, 13-19 parts of Radix adenophorae, 13-15 parts of dried scallop, 8-14 parts of Arundina graminifolia, 8-11 parts of Radix ophiopogonis, 8-11 parts of Flos lonicerae, 8-13 parts of Radix rehmanniae preparata and 6-11 parts of Radix glycyrrhizae. Natural traditional Chinese medicine is adopted, the medicine is simple in component and reasonable in combination, has efficacy of clearing lung to relieve exterior syndromes, dispersing lung to reduce phlegm and strengthening body resistance to eliminate pathogenic factors, is extremely high in curing rate and free of toxic and side effect when being used for treating the wind-warm lung-heat disease and has good clinical popularization and application prospect.

The invention discloses a traditional Chinese medicine preparation for treating reflux esophagitis. The traditional Chinese medicine preparation is prepared from the following medicinal materials in parts by weight: 10 parts of tree peony root bark, 10 parts of cape jasmine, 10 parts of herb of resupinate woodbetony, 12 parts of white peony root, 6 parts of radix bupleuri, 10 parts of seed of squarrose agriophyllum, 10 parts of mirabilite, 3 parts of carbonized human hair, 15 parts of pennycress seed, 6 parts of tragacanth, 10 parts of skin on boiled milk, 10 parts of fleshy lysionotus, inula flower, 15 parts of halite, 15 parts of lalang grass rhizome and 10 parts of honeysuckle. Clinical experiments prove that the traditional Chinese medicine preparation for treating reflux esophagitis has excellent curative effect on the improvement of cardinal symptoms of the reflux esophagitis, the elimination of gastric juice reflux, the repair and protection of the esophagus mucosa, and the elimination of mucosal inflammation due to the appropriate selection of the medicinal materials and the proportions thereof, and as the medicine takes effect, the symptoms are lessened, and moreover, the traditional Chinese medicine preparation has good prevention effect on pathogenesis transmission and invasion into viscera and has a great value in clinical application.

The invention discloses a pharmaceutical composition containing radix paeoniae alba and fruit of Chinese wolfberry for preventing and treating eye diseases, wherein the pharmaceutical composition is prepared from the following raw materials in parts by weight: 20-22 parts of the radix paeoniae alba, 22-25 parts of the fruit of Chinese wolfberry, 8-10 parts of rosa davurica pall fruit, 5-6 parts of halenia ellipitica D.Don, 4-5 parts of radix bupleuri, 8-10 parts of cortex moutan, 6-8 parts of flos chrysanthemi, 4-5 parts of herba polygoni capitati, 5-6 parts of radix trichosanthis, 6-8 parts of finless eel blood, 4-5 parts of glossy privet fruit, 8-10 parts of herba dendrobii, 3-4 parts of stem of finet clematis, 5-6 parts of herb of Japan clover, 0-5 parts of mesua ferrea flowers and 0-3 parts of suet. Clinical experiments prove that the pharmaceutical composition disclosed by the invention has a significant effect on preventing and treating the eye diseases.

The invention discloses a traditional Chinese medicine preparation for treating conjunctivitis. The traditional Chinese medicine preparation is prepared from raw materials in parts by weight as follows: 9-14 parts of szechuan lovage rhizomes, 16-20 parts of frosted mulberry leaves, 10-15 parts of Chinese wolfberry root-barks, 13-17 parts of barbary wolfberry leaves, 8-13 parts of Ferula borealis Kuan, 11-16 parts of cassia seeds, 13-18 parts of herb of slenderleaf ixeris, 10-16 parts of lawn pennywort herb, 11-14 parts of reed rhizomes, 7-13 parts of Japanese milkwort herb, 14-16 parts of oriental waterplantain rhizomes, 10-17 parts of Chinese St. John'swort roots, 9-17 parts of Chinese dicliptera herb, 11-15 parts of Chinese usnea and 8-16 parts of common scouring rush herb. The traditional Chinese medicine preparation has the advantages as follows: the medicines are properly compatible, accord with traditional Chinese medicine and modern medicine research theories and have the efficacy of heat clearing, detoxicity, liver heat clearing, eyesight improvement and wind dispelling; the medicines are easy to obtain and low in cost, so that the burden of a patient can be reduced.

The invention discloses a traditional Chinese medicine for treating gastrointestinal dysfunction caused by critical diseases. The traditional Chinese medicine is prepared from the following Chinese medicinal herbs in parts by weight: 5 parts of coptis roots, 2 parts of immature bitter oranges, 3 parts of officinal magnolia barks, 4 parts of medicinal evodia fruits, 5 parts of dried tangerine peels, 3 parts of all-grass of shore podgrass, 3 parts of solanum mammosum roots, 3 parts of skin on boiled milk, 3 parts of salt alkali, 4 parts of manyflower solomonseal rhizome, 3 parts of garlic and 4 parts of distilled liquid of rose. Clinical experiments show that the traditional Chinese medicine has a significant effect on relieving gastrointestinal dysfunction caused by critical diseases due to the combination of the selected suitable Chinese medical herbs at a proper ratio, and the traditional Chinese medicine is safe and has no side or toxic effect and can be also used for preventing related complications.